NCT02977364View on ClinicalTrials.gov

A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2021

Conditions
CarcinomaSolid Tumor, Adult
Interventions
DRUG

HS-10241

Trial Locations (1)

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY